SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001447028-20-000118
Filing Date
2020-08-07
Accepted
2020-08-07 16:24:21
Documents
61
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q abus-20200630.htm   iXBRL 10-Q 1864283
2 EX-10.3 a2020-q210xqex103cross.htm EX-10.3 401068
3 EX-10.4 a2020-q210xqex1041stam.htm EX-10.4 53593
4 EX-10.5 a2020-q210xqex105secon.htm EX-10.5 57715
5 EX-31.1 a2020-q210xqex311.htm EX-31.1 12702
6 EX-31.2 a2020-q210xqex312.htm EX-31.2 12922
7 EX-32.1 a2020-q210xqex321.htm EX-32.1 6009
8 EX-32.2 a2020-q210xqex322.htm EX-32.2 6225
14 abus-20200630_g1.jpg GRAPHIC 56099
  Complete submission text file 0001447028-20-000118.txt   7073292

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20200630.xsd EX-101.SCH 38166
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20200630_cal.xml EX-101.CAL 63912
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20200630_def.xml EX-101.DEF 171386
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20200630_lab.xml EX-101.LAB 435931
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20200630_pre.xml EX-101.PRE 270441
15 EXTRACTED XBRL INSTANCE DOCUMENT abus-20200630_htm.xml XML 1161546
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 201085347
SIC: 2834 Pharmaceutical Preparations